Published in Br J Dermatol on June 01, 2001
The desmosome and pemphigus. Histochem Cell Biol (2008) 1.54
T cell control in autoimmune bullous skin disorders. J Clin Invest (2006) 1.10
Elevated expression of NLRP1 and IPAF are related to oral pemphigus vulgaris pathogenesis. Inflammation (2015) 0.76
Non-infectious environmental antigens as a trigger for the initiation of an autoimmune skin disease. Autoimmun Rev (2016) 0.75
Accuracy of molecular diagnostics in pemphigus and bullous pemphigoid: comparison of commercial and modified mosaic indirect immunofluorescence tests as well as enzyme-linked immunosorbent assays. Postepy Dermatol Alergol (2017) 0.75
Blocking RhoA/ROCK inhibits the pathogenesis of pemphigus vulgaris by suppressing oxidative stress and apoptosis through TAK1/NOD2-mediated NF-κB pathway. Mol Cell Biochem (2017) 0.75
An analysis of the problem of biliary injury during laparoscopic cholecystectomy. J Am Coll Surg (1995) 9.03
Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology (1994) 2.73
Native portal vein embolization for persistent hyperoxaluria following kidney and auxiliary partial liver transplantation. Am J Transplant (2013) 2.05
Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? Am J Transplant (2010) 1.84
Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol (2000) 1.82
The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol (1999) 1.65
The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane. J Invest Dermatol (1997) 1.63
Hemidesmosome formation is initiated by the beta4 integrin subunit, requires complex formation of beta4 and HD1/plectin, and involves a direct interaction between beta4 and the bullous pemphigoid antigen 180. J Cell Biol (1998) 1.58
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol (2015) 1.55
Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant (2007) 1.51
Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview. Allergy (2000) 1.49
The expanding spectrum of IgA pemphigus: a case report and review of the literature. Br J Dermatol (2014) 1.40
Autoantibodies from a patient with paraneoplastic pemphigus bind periplakin, a novel member of the plakin family. J Invest Dermatol (1998) 1.16
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"? Exp Dermatol (2006) 1.13
IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol (2000) 1.11
Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant (2013) 1.11
The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol (2000) 1.10
Diluted blood reperfusion as a model for transplantation of ischemic rat livers: alanine aminotransferase is a direct indicator of viability. Transplant Proc (2010) 1.06
Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J Invest Dermatol (2000) 1.04
Multiple cutaneous osteomas of the face associated with chronic inflammatory acne. J Eur Acad Dermatol Venereol (2006) 1.03
Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. J Am Acad Dermatol (1999) 1.03
Takayasu arteritis and cutaneous necrotizing vasculitis. Dermatology (2000) 1.03
Hepatocyte viability and adenosine triphosphate content decrease linearly over time during conventional cold storage of rat liver grafts. Transplant Proc (2011) 1.01
NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol (2007) 1.01
Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol (1995) 1.00
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest (1998) 1.00
Embryology of congenital diaphragmatic hernia. Semin Pediatr Surg (1996) 0.99
The subcellular distribution of the high molecular mass protein, HD1, is determined by the cytoplasmic domain of the integrin beta 4 subunit. J Cell Sci (1997) 0.97
Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol (2009) 0.96
Autoantibodies against desmocollins in European patients with pemphigus. Clin Exp Dermatol (2009) 0.95
Schönlein-Henoch purpura associated with losartan treatment and presence of antineutrophil cytoplasmic antibodies of x specificity. Br J Dermatol (2001) 0.95
Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid. Arch Dermatol Res (1996) 0.94
The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone. Clin Exp Immunol (2001) 0.93
The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin beta 4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression. J Biol Chem (2001) 0.93
Scalp necrosis in temporal (giant cell) arteritis:implications for the dermatologic surgeon. Clin Exp Dermatol (1996) 0.92
Autoimmune and inherited subepidermal blistering diseases: advances in the clinic and the laboratory. Adv Dermatol (2000) 0.92
Rituximab in refractory autoimmune bullous diseases. Clin Exp Dermatol (2006) 0.92
Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab. Br J Dermatol (2005) 0.91
Preferential usage of TCR-Vbeta17 by peripheral and cutaneous T cells in nickel-induced contact dermatitis. J Immunol (2001) 0.91
Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2. J Invest Dermatol (1998) 0.91
A tattoo complicated by allergic contact dermatitis and panniculitis. J Eur Acad Dermatol Venereol (2013) 0.91
Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol (2011) 0.90
Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole. Dermatology (1992) 0.90
Rapid response of IgA pemphigus of subcorneal pustular dermatosis type to treatment with isotretinoin. J Am Acad Dermatol (2000) 0.90
Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris. Br J Dermatol (2012) 0.89
Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma. Br J Dermatol (1993) 0.89
Focal palmoplantar keratoderma caused by an autosomal dominant inherited mutation in the desmoglein 1 gene. Dermatology (2006) 0.88
Bullous cryothermic dermatitis artefacta induced by deodorant spray abuse. J Eur Acad Dermatol Venereol (2010) 0.88
IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180. J Invest Dermatol (1999) 0.88
Autoimmune progesterone dermatitis: potential role of cutaneous angiogenin expression? Dermatology (2011) 0.88
Rapid improvement of recalcitrant disseminated granuloma annulare upon treatment with the tumour necrosis factor-alpha inhibitor, infliximab. Br J Dermatol (2005) 0.88
Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease. Arch Dermatol Res (2001) 0.88
Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid. J Invest Dermatol (2001) 0.88
Generalized cowpox infection in a patient with Darier disease. Br J Dermatol (2011) 0.87
Comparative analysis of the expression of ERBIN and Erb-B2 in normal human skin and cutaneous carcinomas. Br J Dermatol (2005) 0.87
Laboratory diagnosis of paraneoplastic pemphigus. Br J Dermatol (2013) 0.87
Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects. J Am Acad Dermatol (1996) 0.87
Molecular diagnosis in autoimmune skin blistering conditions. Curr Mol Med (2014) 0.87
Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses. Br J Dermatol (2001) 0.86
[Simultaneous onset of pemphigoid and factor VIII antibody hemophilia]. Hautarzt (2002) 0.86
Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun (2000) 0.86
Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis? Br J Dermatol (2005) 0.86
Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile. J Am Acad Dermatol (2001) 0.85
Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab. Br J Dermatol (2003) 0.85
Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol (2014) 0.85
Subacute cutaneous lupus erythematosus associated with terbinafine. Clin Exp Dermatol (2009) 0.85
IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. J Invest Dermatol (2000) 0.85
IgE autoantibodies against the intracellular domain of BP180. Br J Dermatol (2008) 0.85
A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis. Br J Dermatol (2013) 0.85
Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230. Br J Dermatol (2001) 0.84
[New aspects on the pathogenesis of bullous pemphigoid]. Hautarzt (2000) 0.84
Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice. Br J Dermatol (2008) 0.84
Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita. Br J Dermatol (2010) 0.83
Tufted hair folliculitis associated with pemphigus vulgaris. J Eur Acad Dermatol Venereol (2003) 0.83
[Chronic bullous disease of childhood. Long-term therapy over 8 years with 4,4'-diaminodiphenylsulfone]. Hautarzt (2012) 0.83
Pyogenic granuloma-like lesions during capecitabine therapy. Br J Dermatol (2002) 0.83
Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia. Br J Dermatol (2005) 0.82
In vivo confocal laser scanning microscopy for non-invasive diagnosis of pemphigus foliaceus. Skin Res Technol (2009) 0.82
Systemic light-chain amyloidosis revealed by progressive nail involvement, diffuse alopecia and sicca syndrome: report of an unusual case with a review of the literature. Dermatology (2014) 0.82
Tonography in cornea guttata. A preliminary report. Arch Ophthalmol (1967) 0.82
Hemidesmosomes: molecular organization and their importance for cell adhesion and disease. Handb Exp Pharmacol (2004) 0.82
Adult-onset Still's disease with persistent plaques. Br J Dermatol (1999) 0.82
Treatment of primary anetoderma with colchicine. J Am Acad Dermatol (1998) 0.82
Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes. Clin Exp Immunol (2004) 0.82
Combined complete C5 and partial C4 deficiency in humans: clinical consequences and complement-mediated functions in vitro. Clin Immunol Immunopathol (1990) 0.82
Interaction of BP180 and alpha6beta4. J Invest Dermatol (1999) 0.81
Genomic organization of the mouse beta 1 gene: conservation of the beta 1D but not of the beta 1B and beta 1C integrin splice variants. Cell Adhes Commun (1996) 0.81
Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol (2001) 0.81
HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy. Autoimmunity (1999) 0.81
Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol (2001) 0.81
Pemphigoid gestationis: maternal sera recognize epitopes restricted to the N-terminal portion of the extracellular domain of BP180 not present on its shed ectodomain. Br J Dermatol (2003) 0.81
Epidermolysis bullosa acquisita with ultraviolet radiationsensitivity. Br J Dermatol (2000) 0.81